← Scroll for more →
Upstream Bio, Inc. (UPB)
Pharmaceutical Preparations
Latest Price
$2.79
TTM P/E
--
Normalized P/E
--
TTM Div Yield
--
Fwd Div Yield
--
Book Value
4.98
P/B Ratio
0.56
Institutional Ownership
92.4% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| FMR LLC | 8.16M | $56.0M | 14.90% | +61.3K | 2026-06-30 |
| Orbimed Advisors LLC | 5.69M | $39.0M | 10.40% | -- | 2026-06-30 |
| Norges Bank | 3.77M | $26.0M | 6.88% | +886.0K | 2026-06-30 |
| BlackRock, Inc. | 3.75M | $25.0M | 6.85% | +382.7K | 2026-06-30 |
| Decheng Capital LLC | 2.72M | $18.0M | 4.98% | -- | 2026-06-30 |
| Enavate Sciences GP, LLC | 2.46M | $17.0M | 4.49% | -- | 2026-06-30 |
| Vanguard Capital Management LLC | 1.88M | $12.0M | 3.43% | +3.2K | 2026-06-30 |
| Millennium Management LLC | 1.14M | $7.0M | 2.09% | +206.5K | 2026-06-30 |
| D. E. Shaw & Co., Inc. | 1.04M | $7.0M | 1.89% | +215.6K | 2026-06-30 |
| JPMorgan Chase & Co | 1.01M | $7.0M | 1.85% | +901.8K | 2026-06-30 |